- Type
- Beta hydroxy acid
- How serious
- Moderate severity
- Evidence
- Moderate evidence
Why it is flagged
Low-concentration rinse-off use is generally considered acceptable; leave-on products above 2% and oral salicylates are advised against in pregnancy.
Health topics it bears on
Sources
- Cosmetic Ingredient Hotlist Health Canada, 2025
- Draft screening assessment - Salicylates group Environment and Climate Change Canada and Health Canada, 2020
- Regulation (EC) No 1223/2009 on cosmetic products (consolidated text of 1 May 2026) European Union (EUR-Lex), 2026
- Commission Regulation (EU) 2019/1966 amending and correcting Annexes II, III and V to Regulation (EC) No 1223/2009 on cosmetic products European Commission, 2019
Also listed as
beta hydroxy acid, 2-hydroxybenzoic acid, willow bark extract, salix alba bark extract, acide salicylique, ácido salicílico, salicylsäure